1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. 2015.
http://globocan.iarc.fr
. Accessed 16 June 2015.
2. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103(6):1541–9. doi:
10.1111/j.1572-0241.2008.01875.x
.
3. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116(3):544–73. doi:
10.1002/cncr.24760
.
4. • Sung JJ, Lau JY, Goh KL, Leung WK. Asia Pacific Working Group on Colorectal C. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6(11):871–6. doi:
10.1016/S1470-2045(05)70422-8
. A comprehensive review on the current epidemiology of CRC in Asia.
5. • Gelband H, Jha P, Sankaranarayanan R, Horton S, World Bank. Cancer. Disease control priorities, vol. 3. Washington, DC: The World Bank; 2015. Chapter 6 is a comprehensive review on current global epidemiology of CRC and effective intervention, especiallly screening, to reduce its disease burden. Various screening modalities and strategies were addressed and compared